key: cord-0884636-4i7476ig
authors: Mermel, Leonard A.
title: When should a patient with prior COVID-19 infection be placed in isolation precautions if readmitted months later?
date: 2020-08-06
journal: Infection control and hospital epidemiology
DOI: 10.1017/ice.2020.408
sha: bcc1c48d5ef18f60e5382fbebeeb64de56583a1b
doc_id: 884636
cord_uid: 4i7476ig

nan

To the Editor-In our hospital system, we do not consider the possibility of reinfection unless a patient had a positive SARS-CoV-2 PCR detected in a nasopharyngeal or nasal swab specimen >3 months from the first such positive PCR test or before then if immunocompromised. 1 However, we have had patients previously admitted with COVID-19 pneumonia, discharged with waxing and waning SARS-CoV-2 PCR positivity over the following 12-13 weeks, and found to be PCR positive with high PCR cycle target thresholds when they were readmitted. These patients' initial, severe infection has led to prolonged PCR positivity. 2 Extracellular vesicles released from infected cells may promote infection prior to the development of an immune response. 3 However, it is possible that RNA and/or other viral fragments released from cells over the days and weeks thereafter continue to prime the immune system 4-6 such that reinfection during this time is unlikely, as it may be for weeks thereafter. If true, it makes more sense to not consider reinfection in immunocompetent patients until >3 months after the last positive SARS-CoV-2 PCR result rather than the first one. Such a policy would have profound implications: it would reduce the need for personal protective equipment that otherwise would be used for placing such patients in isolation precautions if readmitted. Future research is needed to determine whether viral fragments released from cells after active infection has resolved promote prolonged immunity to reinfection such that isolation precautions do not need to be reinstituted until 3 months after the last positive SARS-CoV-2 test.

Duration of Isolation and Precautions for Adults with COVID-19

Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19)

Exosome-mediated transfer of ACE2 (angiotensin converting enzyme 2) from endothelial progenitor cells promotes survival and function of endothelial cell

Correlation between viral RNA shedding and serum antibodies in individuals with coronavirus disease 2019

The role of extracellular vesicles in COVID-19 virus infection

Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection

Acknowledgments.Financial support. No financial support was provided relevant to this article.Conflicts of interest. The author reports no conflicts of interest relevant to this article.